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A B S T R A C T
This study explored knowledge of cervical cancer risk factors among cervical screening non-participants in Great
Britain. The aim was to identify knowledge gaps that could be targeted in screening information materials or
public education campaigns. We used a cross-sectional design to survey women aged 25 to 64 years living in
Great Britain, identiﬁed as cervical screening non-participants through self-report questions. Data were collected
via a household survey. Survey questions measured awareness of risk factors for cervical cancer and socio-
demographic factors. Screening non-participants were included in the study (n=793) and classiﬁed into non-
participant groups based on the Precaution Adoption Process Model. Across the sample, 57% of participants
identiﬁed ‘not going for regular smear tests’ as a risk factor for cervical cancer. Women who intended to be
screened were more likely to identify this risk factor than other non-participant groups (OR=2.13, 95% CI:
1.51–2.99). Women age 55–64 years (OR=0.60, 95% CI: 0.39–0.93) and women from non-white ethnic
backgrounds (OR=0.70, 95% CI: 0.52–0.94) were less likely to recognise this risk factor. Recognition was lower
for ‘infection with human papillomavirus’ (41%). Just over half the sample were aware that screening non-
attendance is associated with increased cervical cancer risk, suggesting that non–attendance at screening is not
always based on an accurate understanding of the oﬀer. Overall, non-participants are poorly informed about
cervical cancer risk factors and further work is needed to ensure that women are making informed choices about
(non-) participation.
1. Introduction
In England, approximately 2500 women are diagnosed with cervical
cancer each year and 680 die of the disease (CRUK, 2016). Cervical
screening reduces the incidence of and mortality from cervical cancer
by detecting abnormal cells on the cervix before they become can-
cerous. However, coverage is sub-optimal and continues to fall year-on-
year across all age groups (NHS, 2018). Most countries that oﬀer cer-
vical screening encourage women to make an informed choice about
participating. In England, the risks and beneﬁts of screening are out-
lined in an information leaﬂet which is posted to women with an in-
vitation letter, to facilitate informed choice. Similar leaﬂets are sent in
Scotland and Wales. The leaﬂets describe the risk factors for cervical
cancer, including the role of the human papillomavirus (HPV) and the
risk of not attending regularly for screening.
Despite such eﬀorts, awareness of risk factors for cervical cancer,
and particularly the role of HPV, has historically been low in the gen-
eral population (Hendry et al., 2012; Klug et al., 2008; Low et al.,
2012). Research has also found that at-risk groups, such as cigarette
smokers, are unaware of their increased risk of cervical cancer (Marteau
et al., 2002). These ﬁndings are a cause for concern and suggest that
non-participants may not be making informed choices about screening.
Population cervical screening programmes are increasingly
adopting HPV-based screening (e.g. Ronco et al., 2014). Primary HPV
testing has been introduced in Australia, the Netherlands and New
Zealand (Brotherton et al., 2016), and will be rolled out across England
in 2019 (NSC, 2016). Such policy changes require information mate-
rials to be updated. To optimise informed choice, educational materials
should address key knowledge gaps.
This study used data from our previously reported survey (Marlow
et al., 2017) to assess knowledge of cervical cancer risk factors among
screening non-participants. Women were classiﬁed into a stage of
screening uptake based on the Precaution Adoption Process Model
(PAPM; Weinstein, 1988). Using the model, screening non-participants
were divided into: ‘unaware’ of screening, ‘unengaged’, ‘undecided’
about screening, ‘decided not’ to be screened and ‘intending to be
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screened’ (but currently overdue). Associations between risk factor
knowledge, PAPM stage and socio-demographic variables were ex-
plored.
2. Methods
2.1. Design
A cross-sectional design was employed. Data collection was out-
sourced to Kantar TNS, a market research company, who conduct
weekly population-based surveys. All data were collected via a house-
hold survey conducted in January and February 2016. No incentives
were oﬀered for participation.
2.2. Participants
All screening-eligible women (aged 25 to 64) living in Great Britain
were invited to participate in the survey. Women who had been diag-
nosed with cervical cancer, had a hysterectomy, or who provided in-
suﬃcient data to determine their screening status were excluded. Here
we report analyses of a sub-sample of participants who were either
overdue for screening (women aged 25 to 49 who had not been
screened in the last 3 years and women aged 50 to 64 who had not been
screened in the last 5 years) or did not intend to go when next invited.
2.3. Procedure
Ethical approval was granted by UCL Research Ethics Committee
(ref: 7585/001). Data collection is described in detail elsewhere
(Marlow et al., 2017). Brieﬂy, women were asked questions regarding
their screening history and future intentions to attend, to determine
eligibility (see Appendix A). Their responses determined their stage of
adoption for screening based on the PAPM (Weinstein, 1988), before
they were asked a series of questions about their knowledge of risk
factors for cervical cancer using items derived from the validated Cer-
vical Cancer Awareness Measure (Simon et al., 2012). Eight established
risk factors for cervical cancer were presented. Participants were asked
to state their agreement that each factor may increase a woman's
chance of developing cervical cancer using a 5-point Likert scale from
‘strongly disagree’ to ‘strongly agree’. Participants could also respond
‘don't know’. Socio-demographic factors previously linked with
screening attendance including age, social grade and ethnicity were
also assessed.
2.4. Analyses
All analyses were carried out using IBM SPSS (version 22). The
proportion and distribution of missing data was explored. Participants
who did not respond to any of the eight risk factor items were excluded
from all analyses. Kantar TNS provide sampling weights which can be
applied to ensure the data are population-representative in relation to
age, social grade and region. All analyses were weighted using the
complex samples function in SPSS. Knowledge of each risk factor was
recoded into ‘aware’ (for strongly agree or agree responses) vs. ‘unaware’
(for neither agree nor disagree, disagree, strongly disagree or don't know
responses). A series of logistic regressions were conducted to determine
predictors of knowledge (aware vs. unaware) of each risk factor for
cervical cancer. Adjusted logistic regression models are presented as
Appendix A.
3. Results
3.1. Participant characteristics
Of 793 screening non-participants in the survey, 761 responded to
at least one risk factor item and were included in the current analyses.
The majority of participants were White British/Irish (62%) and had
positive intentions to be screened (52%). There was good representa-
tion of women from all occupational social grades; sample character-
istics (weighted and unweighted) are presented in Appendix A.
3.2. Knowledge of risk factors for cervical cancer
Knowledge of each risk factor is shown in Table 1. The most widely
recognised was ‘not going for regular smear (Pap) tests’ (57% aware-
ness), followed by ‘having many sexual partners’ (48%). Participants
were least aware of the following risk factors: ‘infection with HPV’
(41%), ‘starting to have sex at a young age’ (35%) and ‘long term use of
the contraceptive pill’ (29%).
3.3. Predictors of risk factor knowledge
Predictors of risk factor knowledge (aware vs. unaware) were as-
sessed (see Table 2). Women who intended to be screened were more
like to identify ‘not going for regular smear tests’ as a risk factor than
the other non-participant groups. Women who were undecided, had
decided not to be screened, or intended to be screened were also more
aware of the risk of having many sexual partners than women who were
unengaged or unaware of screening; knowledge of all other risk factors
was similar across PAPM groups. Women aged 45–54 were less likely to
identify ‘smoking any cigarettes at all’ and ‘having a weakened immune
system’ as risk factors than women in the 25–34 age group. These as-
sociations remained in adjusted analyses (see Appendix A). Women
aged 55–64 were less likely to identify ‘not going for regular smear
tests’ compared to women aged 25–34 years. This association was at-
tenuated in adjusted analyses. Women in social grades C2 and E were
less likely to identify ‘infection with HPV’ and ‘having many sexual
partners’ as risk factors than women in the highest social grade (A/B).
Table 1
Knowledge of risk factors for cervical cancer (n=761, weighted data).
Aware Unaware
Strongly agree/agree Strongly disagree/disagree Neither agree nor disagree Don't know
N (%) N (%) N (%) N (%)
Not going for regular smear (Pap) tests 431 (56.5) 111 (14.6) 131 (17.2) 82 (10.8)
Having many sexual partners 362 (47.5) 135 (17.7) 150 (19.6) 104 (13.7)
Having a weakened immune system 340 (44.7) 127 (16.6) 170 (22.3) 121 (16.0)
Smoking any cigarettes at all 329 (43.2) 184 (24.2) 162 (21.3) 84 (11.1)
Infection with chlamydia 324 (42.5) 106 (13.9) 188 (24.6) 139 (18.3)
Infection with HPV (human papillomavirus) 309 (40.5) 81 (10.6) 162 (21.2) 205 (26.9)
Starting to have sex at a young age 267 (35.1) 179 (23.5) 187 (24.6) 116 (15.2)
Long term use of the contraceptive pill 220 (28.8) 164 (21.5) 241 (31.6) 130 (17.1)
Note. Missing data due to participants who responded ‘Refused’.
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Compared with White British/Irish women, women from other ethnic
groups were less likely to identify ‘not going for regular smear tests’ as a
risk factor and this association remained in adjusted analyses (see Ap-
pendix A).
4. Discussion
This study measured awareness of risk factors for cervical cancer
among screening non-participants in Britain. Adequate knowledge,
particularly regarding the increased risk associated with screening non-
participation, is a key aspect of informed choice (Marteau et al., 2001).
The most widely recognised risk factor was screening non-atten-
dance; however only just over half the sample agreed that this may
increase a woman's chance of developing cervical cancer. Given that
participants were asked to identify risk factors from a list provided,
rather than recall them from memory, it is likely that unprompted risk
factor knowledge would be considerably lower than the results from
this survey indicate (Waller et al., 2004). The proportion of women who
identiﬁed risk factors in this study was notably lower than in a previous
study of adult women in Britain recruited using similar methods, but
not selected on the basis of their screening status (Low et al., 2012).
Low et al. (2012) reported higher proportions of women recognising all
risk factors (e.g. not going to regular smear tests; 75%), suggesting that
risk factor knowledge is probably lower in women who are screening
non-participants. In our study, all participants should previously have
been sent information regarding the screening programme and its aims,
but in line with previous work in the colorectal screening context
(Kobayashi et al., 2016), our ﬁndings suggest that many women may
not read or remember this information. These ﬁndings suggest that i)
many women are not making an informed decision about non-partici-
pation and ii) the screening information materials, in their current
format, may not be suﬃcient to educate all screening-eligible women
Table 2
Unadjusted logistic regression models of predictors of risk factor knowledge (n= 761, weighted data).
HPV Sex at young age Many partners Smoking
% aware OR (95% CI) % aware OR (95% CI) % aware OR (95% CI) % aware OR (95% CI)
Age group
25–34 40.2 1.00 34.0 1.00 45.1 1.00 47.0 1.00
35–44 48.4 1.39 (0.98–1.99) 36.6 1.12 (0.78–1.62) 49.5 1.20 (0.84–1.70) 41.6 0.80 (0.56–1.14)
45–54 35.2 0.81 (0.53–1.23) 37.1 1.15 (0.76–1.74) 51.4 1.29 (0.86–1.93) 37.1 0.66 (0.44–1.00)
55–64 35.1 0.80 (0.51–1.27) 32.1 0.92 (0.58–1.46) 43.8 0.95 (0.61–1.47) 46.7 0.99 (0.64–1.52)
PAPM stage
Unaware 35.3 1.00 31.8 1.00 39.3 1.00 42.7 1.00
Unengaged 34.1 0.95 (0.45–2.02) 35.9 1.20 (0.57–2.56) 40.0 1.03 (0.50–2.14) 42.6 1.00 (0.49–2.05)
Undecided 40.3 1.24 (0.41–3.71) 35.8 1.20 (0.40–3.61) 68.9 3.41 (1.12–10.41) 43.3 1.03 (0.36–2.97)
Decided not 47.4 1.65 (1.03–2.65) 37.7 1.30 (0.80–2.11) 54.3 1.83 (1.15–2.93) 37.4 0.80 (0.50–1.29)
Intender 41.8 1.32 (0.93–1.86) 36.0 1.21 (0.85–1.72) 49.6 1.52 (1.08–2.13) 45.3 1.11 (0.79–1.56)
Social grade
AB (highest) 48.6 1.00 35.0 1.00 56.4 1.00 46.2 1.00
C1 46.3 0.91 (0.57–1.45) 39.5 1.21 (0.75–1.97) 47.6 0.70 (0.44–1.12) 43.6 0.90 (0.56–1.44)
C2 32.1 0.50 (0.30–0.84) 29.8 0.79 (0.46–1.34) 42.5 0.57 (0.35–0.95) 36.6 0.67 (0.40–1.11)
D 37.3 0.63 (0.39–1.03) 34.7 0.99 (0.59–1.64) 46.6 0.68 (0.41–1.10) 47.3 1.05 (0.64–1.70)
E (lowest) 33.7 0.54 (0.32–0.89) 34.2 0.96 (0.57–1.62) 43.4 0.59 (0.36–0.98) 42.1 0.85 (0.52–1.39)
Ethnic group
White British/Irish 42.2 1.00 37.3 1.00 49.5 1.00 44.3 1.00
Other 38.4 0.86 (0.63–1.15) 32.1 0.79 (0.58–1.08) 45.1 0.84 (0.63–1.12) 42.2 0.92 (0.68–1.23)
Contraceptive pill Chlamydia Regular screening Weakened immune system
% aware OR (95% CI) % aware OR (95% CI) % aware OR (95% CI) % aware OR (95% CI)
Age group
25–34 31.9 1.00 42.3 1.00 56.6 1.00 53.4 1.00
35–44 32.6 1.03 (0.71–1.50) 46.5 1.18 (0.83–1.69) 63.6 1.34 (0.93–1.91) 42.5 0.64 (0.45–0.92)
45–54 22.7 0.63 (0.40–1.00) 42.4 1.00 (0.67–1.51) 56.6 1.00 (0.67–1.50) 38.0 0.53 (0.35–0.80)
55–64 24.4 0.69 (0.42–1.13) 36.4 0.78 (0.50–1.23) 44.1 0.60 (0.39–0.93) 38.9 0.56 (0.36–0.86)
PAPM stage
Unaware 32.6 1.00 38.3 1.00 48.5 1.00 46.5 1.00
Unengaged 26.6 0.75 (0.35–1.62) 41.9 1.16 (0.55–2.44) 48.7 1.01 (0.50–2.06) 50.6 1.18 (0.58–2.40)
Undecided 18.8 0.48 (0.13–1.79) 35.0 0.87 (0.28–2.72) 32.8 0.52 (0.18–1.52) 52.6 1.27 (0.45–3.64)
Decided not 28.4 0.82 (0.49–1.36) 45.9 1.37 (0.85–2.19) 41.1 0.74 (0.47–1.19) 46.7 1.01 (0.63–1.61)
Intender 27.7 0.79 (0.55–1.13) 44.1 1.27 (0.90–1.79) 66.7 2.13 (1.51–2.99) 42.3 0.84 (0.60–1.18)
Social grade
AB (highest) 25.3 1.00 48.2 1.00 53.9 1.00 38.7 1.00
C1 31.4 1.36 (0.81–2.28) 47.6 0.98 (0.61–1.56) 58.8 1.22 (0.76–1.95) 49.6 1.56 (0.97–2.50)
C2 23.5 0.91 (0.51–1.61) 39.0 0.69 (0.42–1.14) 57.7 1.17 (0.71–1.92) 38.7 1.00 (0.60–1.66)
D 34.1 1.53 (0.90–2.62) 36.4 0.61 (0.38–1.00) 59.5 1.25 (0.77–2.05) 46.6 1.38 (0.85–2.25)
E (lowest) 29.2 1.22 (0.70–2.13) 37.4 0.64 (0.39–1.06) 50.5 0.87 (0.53–1.43) 48.5 1.49 (0.91–2.46)
Ethnic group
White British/Irish 27.5 1.00 41.5 1.00 60.1 1.00 41.7 1.00
Other 31.4 1.21 (0.88–1.66) 44.4 1.12 (0.83–1.51) 51.2 0.70 (0.52–0.94) 49.7 1.38 (1.03–1.85)
Note. OR=unadjusted odds ratio; CI= conﬁdence interval; ‘Social grade’ is determined by the occupation of the Chief Income Earner in the household and is
classiﬁed as follows: AB managerial/professional; C1 supervisory; C2 skilled manual; D semi-skilled/unskilled manual; E casual workers/unemployed.
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about risk factors for cervical cancer. Awareness of the role of HPV was
notably low, which has implications for the introduction of primary
HPV testing in the UK.
The ‘intender’ group was more aware of the increased risk of
screening non-attendance than other PAPM groups. The PAPM
(Weinstein, 1988) proposes that individuals move through a series of
stages before intending to engage in, and then adopting, a health-pro-
tective behaviour. Educating women about the risk of screening non-
attendance may help to shift non-participants through these stages
closer to the ‘intender’ stage. Women aged 50–64 were less aware of the
risk of not attending regularly for screening than younger women. Al-
though older women have received multiple screening invitations, they
may no longer read posted materials, having received similar in-
formation previously. Being regularly screened between the ages of
50–64 years can signiﬁcantly reduce a woman's chance of being diag-
nosed with cervical cancer in older age (Landy et al., 2016), so eﬀective
methods of educating this age-group should be explored.
This survey also found that women from non-white ethnic back-
grounds are less informed about the risk of screening non-participation
than women who identiﬁed as white. Engagement with English-lan-
guage written materials may be lower among ethnic minority groups
(Abdullahi et al., 2009). In addition, this survey was conducted in
English so certain ethnic minority groups were not represented. Thus, it
is likely that awareness of the increased risk associated with screening
non-attendance among ethnic minority women is lower than we have
reported (Jackowska et al., 2012). These ﬁndings add to the body of
literature suggesting that women from non-white ethnic backgrounds
and those whose ﬁrst language is not English face many barriers to
screening and need further support in deciding whether to attend
(Marlow et al., 2015).
Although stratiﬁed random location sampling was employed to re-
duce the risk of bias, the number and details of women who elected not
to participate in the survey was not recorded, so neither the response
rate nor diﬀerences between responders and non-responders could be
determined. Further, the current study did not assess knowledge of HPV
vaccine or vaccine receipt. Finally, due to resource constraints, we were
unable to measure risk factor awareness among women who were up-
to-date with screening so direct comparisons between attenders and
non-attenders could not be made.
It is unlikely that solely increasing risk factor knowledge in this
cohort would increase screening attendance, as personalised risk in-
formation rarely leads to behaviour change without targeting other
psychological factors (French et al., 2017) and previous research has
found that many non-participants do not always engage with educa-
tional leaﬂets (Kobayashi et al., 2016). Nevertheless, our ﬁndings in-
dicate that further public health action is needed to ensure that the aims
of the screening programme regarding informed choice are achieved.
The imminent change to primary HPV screening presents an opportu-
nity to increase awareness of the role of HPV. Future research may
determine the most eﬀective methods of communicating with the
screening-eligible population, including non-leaﬂet approaches, to im-
prove informed choice for HPV-based cervical screening.
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